Can Heart Medicines Hurt My Kidneys?

Cardio Renal Foundation is a 501(c)(3) tax-exempt charity organization. Your donation advances our mission to provide a solution beyond dialysis.

It is one of the most frightening moments in heart and kidney care, and it happens quietly, on paper. You start a new heart or blood-pressure medicine. Two weeks later the lab results come back, and there it is: your creatinine is up. Your kidney number got worse — on the medicine that was supposed to help you. Some people panic. Worse, some quietly stop taking the pill.

Please do not stop it on your own. In many cases, that early rise in creatinine is not the medicine injuring your kidneys. It is the medicine doing its job — and stopping it can do the very harm you were afraid of. Here is the honest picture.

Why Creatinine Often Rises When These Medicines Start

The medicines at the center of this question are usually the blood-pressure and heart medicines known as ACE inhibitors and ARBs — familiar names include lisinopril, enalapril, and losartan. They protect the heart by relaxing blood vessels. Inside the kidney, they also relax the tiny vessel that keeps pressure up inside each filter.

That matters because creatinine is a pressure-sensitive number. Lower the pressure inside the filter and the filter passes a little less creatinine out of the blood — so the level in the blood rises. The kidney itself has not been damaged. The filter is simply running at the lower pressure the medicine was designed to create.

Doctors generally expect a small rise after starting one of these medicines or raising the dose — a rise of up to roughly 30 percent is commonly considered acceptable, as long as it levels off rather than climbing. That is why your team typically rechecks labs a week or two after a start or a dose change: they are watching for the expected settling, not waiting for damage.

The Part That Sounds Backwards: These Medicines Protect Kidneys

Here is what the frightening lab printout does not tell you. Years of high pressure inside those tiny filters is one of the main forces that scars kidneys over time — especially in diabetes and high blood pressure. By lowering that internal pressure, ACE inhibitors and ARBs slow the scarring. They are among the most kidney-protective medicines in regular use, and they are prescribed because of kidney disease as often as in spite of it.

The same pattern now appears with a newer family, the SGLT2 inhibitors — medicines like empagliflozin and dapagliflozin, used for diabetes, heart failure, and kidney protection. Kidney function numbers often dip a little in the first weeks, then hold steadier for years afterward than they would have without the drug. Early dip, long protection: it is the signature of this whole class of medicines, and it is why doctors ask you to ride out the first lab rather than judge by it.

What About the Other Heart Medicines?

• Water pills (diuretics). These change kidney numbers by changing fluid. Drain too much and creatinine rises from simple volume loss; that is usually a dosing question, which is why unexpected rises on a water pill are worth reporting rather than fearing silently.
• Beta blockers. Medicines like metoprolol slow the heart and generally have little direct effect on kidney filters. They are not usually the explanation for a changed kidney number.
• Spironolactone and its relatives. Valuable heart medicines that can raise potassium — which is why they come with scheduled potassium checks, especially alongside an ACE inhibitor or ARB.
• The potassium chapter generally. Several heart medicines nudge potassium upward, and kidneys that already struggle clear potassium slowly. The regular lab monitoring that comes with these prescriptions is not a warning sign. It is the safety system working as designed.

The Real Danger: Stopping Silently

Now the loop that genuinely harms kidneys — and it runs through the heart. If fear of a lab number leads you to stop a heart medicine without telling anyone, the heart failure or blood pressure it was controlling can worsen. A struggling heart pumps less blood forward. The kidneys, which need strong, steady blood flow more than almost any organ, receive less. And that — under-filled kidneys behind a weakening heart — is real kidney injury, the cardiorenal spiral this Foundation exists to explain.

In other words: the medicine with the scary first lab usually protects both organs. Quitting it in secret endangers both. If you are worried about a number, bring the printout and the worry to your doctor together. Adjusting a heart medicine is sometimes the right call — but it is a decision to make with the person who can see your whole picture, including what the medicine is holding back.

What Good Monitoring Looks Like

• Labs rechecked about one to two weeks after starting an ACE inhibitor, ARB, or spironolactone, or after a dose change — sooner if your team asks.
• Potassium watched alongside creatinine; the two travel together with these medicines.
• A rise that keeps climbing past the expected range, or a potassium that runs high, gets reported and addressed — dose adjustments, a search for other causes like dehydration, illness, or an interfering painkiller, rather than panic.
• Illness days matter: vomiting, diarrhea, or not eating and drinking normally can change how these medicines sit. Many teams give specific "sick day" instructions — ask yours what they want you to do when you are ill.

So, can heart medicines hurt your kidneys? A few situations call for real caution, and your monitoring labs exist to catch them. But the famous one — creatinine up after starting a blood-pressure or heart pill — is most often the sound of the medicine working, not harming. Do not let a number on a printout talk you out of a medicine in silence. That conversation belongs with your doctor, and it is worth having out loud.

Heart medicines and kidneys negotiate constantly, and this article referees the negotiation. The Cardio Renal Foundation supports research aimed at the day the negotiation fails entirely: work toward approaches beyond dialysis, including a swallowed capsule designed to remove excess fluid through the gut. Manage the trade-offs here with your doctor; that research is aimed at the future those trade-offs are holding the line toward.

At the Cardio Renal Foundation, we believe plain-language education like this is a genuine first line of defense, and support from readers like you helps us keep publishing it for the patients and families who need it.

This article is informational only and is not meant to replace the advice of your qualified healthcare provider. As with any issues related to your health, check with your doctor. Never start, stop, or change a prescribed medicine without your prescriber's guidance.